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Abstract: It has been shown that sarcosine supplementation stimulates proliferation and invassivenes 
of prostate cells. Nevertheless, the exact molecular mechanism responsible for this phenomenon is not 
known. In the present study we demonstrate that sarcosine increases expression of calmodulin (CaM), 
an important intracellular signaling molecule. Through this, sarcosine activates calmodulin-dependent 
protein kinases signaling. Pathway of activation CaM-dependent protein kinases can activate 
regulation of mitosis, proliferation, cell death, gene transcription and phosphorylation/ 
dephosphorlation of proteins. This is done through CaM binding of four Ca2+ ions. Interestingly, in 
this study, we identified decrese in free Ca2+ correlating with sarcosine-induced up-regulation of CaM. 
The influence of CaM to cell cycle changes was further verified using post transcritrional gene 
silencing using CaM-siRNA complex. Co-treatment of prostate cells with CaM-siRNA and sarcosine 
showed decrease in CaM-dependent kinases and cell invasiveness compared to sarcosine treatment 
only.  
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INTRODUCTION 
Sarcosine is an imino acid and a potential biomarker of prostate cancer (PCa). Concentration of 
sarcosine is substantially increased during PCa progression to its metastasis (Sreekumar et al. 2009).  
Calmodulin (CaM) is a ubiquitous calcium-binding protein (Zayzafoon 2006). It is responsible 
for intracellular interactions connected with regulation of proliferation and malignity (Rasmussen and 
Means 1989). CaM acts primarily through CaM-dependent signalling pathways connected into 
regulatory system important for cellular pathophysiology (Zayzafoon 2006). CaM-dependent protein 
kinases are activated after presence of CaM in neighbouring subunits activated by Ca2+ ions (Rokhlin 
et al. 2007). If CaM is accumulated in sufficient amount, autophosphorylation occurs, leading to 
persistent activation of the enzyme (Wang et al. 2015). The major mediator system affecting cellular 
proliferation driven by Ca2+/CaM is CaM-dependent protein kinase II (CaMKII). CaMKII 
phosphorylate over 40 different proteins, including enzymes, kinases and transcription factors 
(Erickson 2014).  
Our results demonstrate a unique connection between sarcosine and CaM-dependent signaling 
through up-regulation of CaM-dependent kinases. We also show that sarcosine affects Ca2+ 
homeostasis. Moreover, functional siRNA analyses revealed an importance of CaM-sarcosine 
interplay in proliferation and clonogenicity of prostate cells.  
MATERIAL AND METHODS 
Prostatic cell lines 
Three human prostatic cell lines were used for an experiment, representing benign and 
malignant cells: i) the PNT1A human cell line established by immortalization of normal adult prostatic 
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epithelial cells by transfection with a plasmid containing SV40 genome with a defective replication 
origin ii) LNCaP human cell line estabished from an androgen-sensitive metastasis located in the left 
supralavicular lymph node, iii) PC3 human prostate adenocarcionoma cell line established from 
a grade 4 prostatic adenocarcinoma. All cell lines used for experiments were purchased from Health 
Protection Agency Culture Collections (Salisbury, UK).  
Culture conditions and treatment protocols 
All cell lines were culture in RPMI-1640 medium with 10% fetal bovine serum and 
supplemented by penicillin (100 U/mL) and streptomycin (0.1 mg/mL). The cells were maintained at 
37 °C in humidified incubator with 5% CO2. The exogenous supplementation with sarcosine (10 μM) 
and siRNA (200 pM) was initiated after cells reached ~80% confluence. The cells were harvested after 
24; 48 and 72 h for western blotting, after 24 h for immunofluorescence and FURA-2. All experiments 
were designed as five biological replicates (n = 5) measured three times at each time point. 
2D-DIGE proteome alanysis 
Total cellular protein were isolated form cells stimulated by sarcosine (10 μM) after 24 h and 
un-treated group as a control. Compared group of proteins were labeled with fluorescen dyes directly 
and each 50 μg of proteins were separate by isoelectric point (IPG: 7 cm, pH 3 to 10). After that for 
second dimension were used 12.5% SDS-PAGE. Evaluated were different spots of protein expression 
between sarcosine stimulated and un-stimulated group of cells by Azure c600imager (Azure 
Biosystems, Dublin, CA, USA). 
Imunocytometry (ICC) of CaM 
For ICC, the cells were seded into eight-well chamber slides and after 24 h of adherence were 
treated by sarcosine (10 μM). As a control were used cells without treating. Cells were fixated after 
24 h incubation by 4% formaldehyde, permeabilizated by 0.25% Triton X-100, blocked in 5% bovine 
serum albumin in phosphate buffered saline (PBS) and imunostained with primary antibody overnight 
in 4 °C. Detection was accomplished using CruzFluor™ 645 (CFL 645) labeled secondary antibody. 
DNA staining by Hoechst were used for counter. ICC was evaulated by confocal laser scanning 
microscope (CLSM) Carl Zeiss LSM 880 (Carl Zeiss, Jena, Germany).  
Western blot of CaM and CaM-dependent kinases  
Total cellular proteins were extracted with 100 μL of thiourea (2 M) buffer containing protease 
inhibitor cocktail. After electrophoresis, the proteins were electrotransferred onto a polyvinylidene 
fluoride membrane, with the rest of membrane surface blocked in 5% (w/v) bovine serum albumin in 
PBS for 1 h at 37 °C to avert non-specific binding. Membranes were incubated with primary rabbit 
anti-CaM (dilution 1:1000), rabbit anti-CaMKII (dilution 1:1000), rabbit anti-CaMKIV (dilution 
1:200), rabbit anti CaMKK (dilution 1:100), rabbit anti-CaMKK2 (dilution 1:1000) or mouse anti-
GAPDH (dilution 1:700) antibodys, overnight at 4 °C. After washing, membranes were incubated with 
goat  anti-rabbit or goat anti-mouse secondary antibodies HRP-linked (Cell Signalling, Leiden, 
Netherlands)for 1 h at 20 °C. The chemiluminiscence was indicated by Bio-Rad Immun-Star HRP 
Luminol/Enhancer and detecton by Azure c600imager (Azure Biosystems, Dublin, CA, USA). 
Free cytosolic Ca2+  
Intracellular free Ca2+ ions were evaluated by high affinity fluorescent selective indicator. Cells 
were seded into six-well plate and treated by transfection medium with control-siRNA and CaMI-
siRNA (200 pM), sarcosine (10 μM)for 24 h and un-treated cells as a control group. Cells were 
subsequently labeled with Fura 2 acetoxymethyl ester (10 μg/mL) (Fura-2 AM, Abcam). The ratio of 
the emission correlated to the free amount of intracellular Ca2+ concentration. DNA staining by 
elipticine were used for nuclei conterstaining. Imaging was performed using EVOS FL Auto Cell 
Imaging System (Thermo-Fisher, Waltham, MA, USA). 
Wound-healing assay (Scratch test) 
The cells were seeded into 6-well plate to reach confluence ~80%. After seeding a pin was used 
to a scratch and remove cells from a discrete area of the confluent monolayer to form a cell-free zone. 
After that, cells were treated with sarcosine (10 μM), transfection medium with control-siRNA, CaMI-
siRNA and untreated group as a control. After 6; 12, 24 and 48 h, the micrographs of cells were taken 
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using EVOS FL Auto Cell Imaging System and compared with micrographs obtained in 0 h, using 
TScratch software. 
Descriptive statistics 
For the statistical evaluation of the results, the mean was taken as the measurement of the main 
tendency, while standard deviation was taken as the dispersion measurement. Differences between 
groups were analyzed using paired t-test. Unless noted otherwise, the threshold for significance was 
p < 0.05. For analyses Software Statistica 12 (StatSoft, Tulsa, OK, USA) was employed. 
RESULTS AND DISCUSSION 
First, we compared differentially expressed proteins sarcosine treated cells and control non-
treated group. Figure 1 illustratse representative 2D-DIGE proteomic signature with a quantitation of 
expression of spots annotated as CaM (IP 3.9, Mw 17 kDa). It clearly follows from the data that 
sarcosine influences proteome of prostate cells and up-regulates CaM. CaM can be further used in 
cells as an signaling molecule for CaM-dependent pathways, which can be connected with cancer 
progression and invasiveness. 
Figure 1 (A) Representative 2D-DIGE of PCa cells (LNCaP) proteome. Red arrow shows spot 
identified as CaM. (B) Densitometry of CaM spots from 2D-DIGE for tested cell lines in two times of 
treatment (24 and 48 h). 
 
CaM expression was also evaluated by CLSM (Figure 2) that indicates intracellular localization 
of CaM and also a significant up-regulation due to sarcosine treatment. All three tested cell lines show 
increased expression of intracellular CaM after sarcosine supplementation.  
We further investigated CaM expression upon 24 and 48 h of sarcosine stimulation compared 
control. Figure 3 depicts increased expression for CaM in time. Noteworthy, expression of CaM-
dependent kinases decreased after siRNA-mediated knock-down of CaM. This fact demonstrates that 
sarcosine can plausibly affect cell cycle directly through the intracellular messenger CaM. 
Intracellular Ca2+ activates CaM. This means that intracellular level of Ca2+ could be bound and 
homeostasis should be altered. Indeed, different intracellular concentration of Ca2+ (Figure 4) 
correlated with expression of CaM. Lower free Ca2+ concentration shows higher occurrence upon up-
regulation of CaM by sarcosine. Upon silencing of CaM, increased pool of Ca2+ occurs. Upon CaM 
silencing combined with sarocisne exposure, free Ca2+ increases, confirming a direct effect of 
sarcosine to CaM. 
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Figure 2 Representative ICC of CaM in tested cells after 24 h treatment with sarcosine (10 μM) and 
control un-treated group. 
 
 
Figure 3 (A) Western blot validation of CaM expression. (B) Expression of CaM-dependent kinases 
upon CaM silencing and parallel administration to sarcosine. 
 
Figure 4 Concentraion of free intracellular Ca2+in PCa cell after sarcosine treatment and CaM 
silencing. Ca2+ is shown in blue and nuclei in green. The scale bar is 100 µm. 
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CONCLUSION 
Sarcosine up-regulates CaM in prostate-derived cells, and therefore alters the Ca2+ homeostasis 
and pathways drived by CaM-dependend kinases. This signaling cascade can alter cell cycle and 
proliferation. The need of calcium in this processes has been demonstrated many times. Possibility of 
silencing CaM can be a new modality to decrease tumor progression, including frequently developing 
bone methastases.  
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